PDS Biotech launches up to $11.1M registered direct offering; Sep 30 cash $26.2M

PDS Biotechnology Corp

Offering of 5.8M shares (or pre-funded warrants) at $0.91 with warrants exercisable at $1.00 per share.
Initial gross proceeds ~$5.3M; up to additional $5.8M if warrants fully exercised.
Proceeds for VERSATILE-003 Phase 3 trial and FDA discussions for accelerated PDS0101 pathway.
Existing warrants amended: exercise price reduced from $1.50 to $1.00, exercisable six months after close.
60-day lock-up agreements for directors and officers; Craig-Hallum as placement agent at 6.0% fee.

item 1.01 item 2.02 item 7.01 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.